Page last updated: 2024-10-27

fenofibrate and Day Blindness

fenofibrate has been researched along with Day Blindness in 3 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Research Excerpts

ExcerptRelevanceReference
"Numerous studies have reported the efficacy of fenofibrate for patients with diabetic retinopathy (DRP)."7.91Efficacy of fenofibrate for diabetic retinopathy: A systematic review protocol. ( Han, L; Liu, HW; Qi, YX; Su, XJ, 2019)
"Numerous studies have reported the efficacy of fenofibrate for patients with diabetic retinopathy (DRP)."3.91Efficacy of fenofibrate for diabetic retinopathy: A systematic review protocol. ( Han, L; Liu, HW; Qi, YX; Su, XJ, 2019)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Su, XJ1
Han, L1
Qi, YX1
Liu, HW1
Pelletier, AL1
Rojas-Roldan, L1
Coffin, J1
Nagra, PK1
Ho, AC1
Dugan, JD1

Reviews

1 review available for fenofibrate and Day Blindness

ArticleYear
Vision Loss in Older Adults.
    American family physician, 2016, Aug-01, Volume: 94, Issue:3

    Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antihypertensive Agents; Ascorbic Acid; Bevacizuma

2016

Other Studies

2 other studies available for fenofibrate and Day Blindness

ArticleYear
Efficacy of fenofibrate for diabetic retinopathy: A systematic review protocol.
    Medicine, 2019, Volume: 98, Issue:14

    Topics: Diabetic Retinopathy; Disease Progression; Fenofibrate; Humans; Hypolipidemic Agents; Macular Edema;

2019
Lipemia retinalis associated with branch retinal vein occlusion.
    American journal of ophthalmology, 2003, Volume: 135, Issue:4

    Topics: Combined Modality Therapy; Diet Therapy; Exercise Therapy; Female; Fenofibrate; Humans; Hyperlipopro

2003